
Zollinger Ellison Syndrome Market Analysis Report 2025: Novartis, GSK, Bayer, Pfizer, And Bristol Myers Squibb Dominate
(MENAFN- GlobeNewsWire - Nasdaq) Enhanced treatment options, precision medicine, and advanced diagnostics are fueling growth across major markets Dublin, June 27, 2025 (GLOBE NEWSWIRE) -- The "Zollinger Ellison Syndrome Market Report and Forecast 2025 …